Progress, Potential, and Possibilities Podcast / Show
Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor
Episodes
804 episodes
Can AI Rescue Failed Drugs? The Hidden Patients Inside Clinical Trials | Vin Singh, CEO, BullFrog AI
Pharma has spent decades building a graveyard of failed drugs — but hidden inside that data may be treatments that actually worked… for someone.Vin Singh is Founder and CEO of BullFrog AI ( https://bullfrogai.com/ ), a company working a...
•
43:27
A World Where Anyone Who Needs a Bone Marrow Transplant Gets One - Kevin Caldwell - CEO - Ossium Health
Bone marrow transplants have always depended on finding the right donor at the right time. But what if bone marrow could be stored, shipped, and used on demand—just like a drug? That’s exactly what Ossium Health is now showing in human clinical...
•
45:17
Restoring Function, Not Just Treating Disease - The Rise of Physiatry - Dr. Michael Yochelson, MD - Chief Medical Officer, Shepherd Center - Board of Governors, American Academy of Physical Medicine and Rehabilitation
There’s an entire medical specialty, Physiatry, dedicated not to treating disease - but to helping patients regain their lives. And most people have never heard of it.Dr. Michael Yochelson is a Physiatrist and a nationally recognized le...
•
43:28
Inside The Race To Build Better Lyme Disease Diagnostics and Treatments - David Walsey - Executive Director, Bay Area Lyme Foundation
Lyme disease affects hundreds of thousands of people every year—and yet we still struggle to diagnose it, treat it, and prevent it.David Walsey is a strategic biotech leader with more than two decades of experience helping public life s...
•
38:58
The First Male Birth Control Pill Is Finally Here | Akash Bakshi - CEO, YourChoice Therapeutics
For decades, male birth control has remained one of medicine’s most elusive goals. Now, a new non-hormonal pill is entering human trials—and could finally change the balance of reproductive responsibilityAkash Bakshi is CEO and Co-Found...
•
46:04
Mineral Biology: What a Crayfish Can Teach Us About Human Health | Eden Ben - CEO, Amorphical
There’s an animal that can rebuild its entire body structure in just a few days—and it might hold clues to a new kind of medicine.Eden Ben is CEO of Amorphical ( https://www.amorphical.com/ ), a pioneering biotech company out of Israel ...
•
38:47
The AI Chip That Thinks Like a Brain (And Uses Almost No Power) - Sean Hehir - CEO, BrainChip
What if AI didn’t need massive data centers—and could think more like the human brain?Sean Hehir is the Chief Executive Officer of BrainChip ( https://brainchip.com/ ), a pioneer in neuromorphic computing and ultra-low-power artificial ...
•
37:23
The Science Behind The Future Of Snacking - Norberto Chaclin - Executive Vice President, Chief Research & Development Officer - Mondelēz International
Norberto Chaclin is Executive Vice President, Chief Research & Development Officer of Mondelēz International ( https://www.mondelezinternational.com/about-us/leadership/executive-team/norberto-chaclin/ ), a global snacking leader with 2025 ...
•
41:19
The Defense-Tech Startup Reinventing Military Logistics | Brandon Florian - Co-Founder and Chief Commercial Officer - Grid Aero
Modern warfare is changing—and it’s not just about weapons anymore.The real battle may be logistics, and autonomous systems are about to transform how wars are fought and sustained.Brandon Florian is Co-Founder and Chief Commercial ...
•
41:13
Brain-Computer Interfaces Go Real-World: Defense, AI, and Human Performance | Adam Molnar - Co-Founder, COO and Vice President of Strategic Partnerships, Neurable
Adam Molnar is Co-Founder, COO and Vice President of Strategic Partnerships at Neurable ( https://www.neurable.com/ ), a pioneering neurotechnology company developing real-time brain-computer interface systems that translate neural signals into...
•
46:00
Engineering Superintelligence: The AI That Could Run Infrastructure - Greg Fallon, CEO, Geminus AI
Greg Fallon is the CEO of Geminus AI ( https://www.geminus.ai/ ), a company developing real-time, physics-native artificial intelligence designed to operate complex industrial and energy systems. His work focuses on combining engineering simula...
•
42:42
The Future of Surgery: AI, Robotics & The Intelligent Operating Room - Vignesh Shetty, Vice President of AI and Product Development, Medtronic Cranial and Spine Therapies
Artificial intelligence and robotics are rapidly transforming surgery. In this episode we explore the future of the operating room with Medtronic’s vision for the AiBLE ecosystem and the newly cleared Stealth AXiS surgical platform — technologi...
•
39:38
How Quantum Technology Will Transform The Future - Dr. Javad Shabani, Ph.D. - Director, NYU Quantum Institute - Director, Center of Quantum Information Physics
Dr. Javad Shabani, Ph.D. ( https://as.nyu.edu/faculty/javad-shabani.html ) is Professor of Physics; Director of the Center of Quantum Information Physics ( https://as.nyu.edu/departments/physics/research/center-for-quantum-information-physics.h...
•
58:54
How An FBI Intelligence Analyst Ended Up Transforming Pharma R&D - Tara Austraat-Churik - Partner, Blue Matter
Tara Austraat-Churik is a Partner at Blue Matter ( https://bluematterconsulting.com/ ), a strategic consulting firm serving the life sciences industry, bringing new approaches to consulting with original ideas that deliver a meaningful impact.&...
•
56:33
AI Coding Assistants Gone Rogue? Pramin Pradeep - Co-Founder and CEO of BotGauge - Shadow Code & Software Risk
For most of the history of computing, software systems were written by humans and—at least in theory—understood by humans.But with AI coding assistants now embedded in everyday development workflows, we may be entering an era where larg...
•
33:17
The Future of Psychedelic Medicine | Interview with Compass Pathways CEO Kabir Nath
Kabir Nath is Chief Executive Officer of Compass Pathways ( https://compasspathways.com/ ), a biotechnology company pioneering evidence-based psychedelic innovation for serious mental health conditions.Kabir brings nearly three de...
•
38:10
Education, Dignity & Opportunity: Supporting Refugee Women Worldwide - Lacey Stone - Chief Development Officer - USA for UNHCR
Lacey Stone is Chief Development Officer at USA for UNHCR ( https://www.unrefugees.org/about-us/ ), the U.S. partner of United Nations High Commissioner for Refugees ( UNHCR - https://www.unhcr.org/ ), the UN Refugee Agency.UNHCR is a g...
•
42:38
How Multi-Cancer Early Detection Is Reshaping Oncology - Dr. Tomasz Beer, MD - Chief Medical Officer for Multi-Cancer Early Detection - Exact Sciences
Dr. Tomasz Beer, MD is a nationally recognized medical oncologist and clinical research leader who serves as Chief Medical Officer for Multi-Cancer Early Detection at Exact S...
•
44:47
Reversing Brain Disorders - Synaptic Regeneration And Correction Explained - Dr. Sharron Gargosky, Ph.D. - Chief Clinical Officer, Spinogenix, Inc.
Dr. Sharron Gargosky, Ph.D. is Chief Clinical Officer of Spinogenix, Inc. ( https://spinogenix.com/ ), a clinical-stage company pioneering a new class of therapeutics designed to reverse synaptic loss and dysfunction in the brain.Spinog...
•
38:33
Finding Light In Life’s Final Chapter At The Derian House Children's Hospice - The Little Things Documentary- Paul Woodard, Producer
Paul Woodward ( https://www.imdb.com/name/nm2813295/ ) is a filmmaker, storyteller, and advocate whose deeply personal work has touched audiences around the world.Paul is the producer of the feature documentary The Little Things ( https...
•
42:24
Rethinking Alzheimer’s: The Brain-Heart-Immune Axis with Dr. Allison Reiss, MD - Associate Professor of Medicine and Head of the Inflammation Laboratory, NYU Grossman Long Island School of Medicine
Dr. Allison Reiss, MD is an internal medicine physician, molecular biologist, and educator whose career sits at the critical intersection of inflammation, cardiometabolic disorders, and neurodegeneration.Dr. Reiss serves as Associate Pr...
•
47:54
Alzheimer’s Disease Modification vs Prevention - Where the Science Stands - Dr. Kevin Rynearson, Ph.D. - Chief Scientific Officer, Acta Pharmaceuticals / Head of Research, CogniSHIELD Global
Dr. Kevin Rynearson, Ph.D. is a medicinal chemist and translational neuroscientist focused on developing disease-modifying therapies for Alzheimer’s disease.Over more than a decade, Dr. Rynearson's work has centered on the design and op...
•
39:39
The Measurement Gap in Medicine - Injectable Sensors That Could Change Everything - Dr. Ben Hwang, CEO, Profusa
Dr. Ben Hwang, Ph.D. is Chairman and CEO of Profusa ( https://profusa.com/ ), a pioneering bioengineering company developing tissue-integrated biosensors designed to continuously measure key chemical markers within the body. Profusa’s mission i...
•
1:02:05
Building Progress in Friedreich’s Ataxia - Advocacy, Science, and the FALCON Trial - Thomas Hamilton - Co-Founder, CureFA Foundation
Thomas Hamilton is a Board Director Friedreich's Ataxia Research Alliance ( FARA - https://www.curefa.org/ ), Co-Founder of the CureFA Foundation ( https://curefafoundation.org/ ), which supports diverse and innovative research strategie...
•
31:50
How Gardening May Protect the Aging Brain - Donna Letier - Co-Founder & CEO, Gardenuity
Donna Letier is the Co-Founder and CEO of Gardenuity ( https://gardenuity.com/ ), a gardening and well-being company dedicated to helping people grow healthier lifestyles through accessible, personalized gardening experiences.An entrepr...
•
36:22